Itau Unibanco Holding S.A. Orchard Therapeutics PLC Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.16 - $2.23 $13,466 - $25,888
-11,609 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$2.24 - $4.29 $8,476 - $16,233
3,784 Added 48.36%
11,609 $27,000
Q2 2021

Aug 17, 2021
BUY
$4.39 - $7.23 $34,351 - $56,574
7,825 New
7,825 $34,000

Others Institutions Holding ORTX

# of Institutions
4
Shares Held
545K
Call Options Held
0
Put Options Held
0
View Full List

About Orchard Therapeutics plc

ORTX Quotes by TradingView
  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email